PROTHIPENDYL HYDROCHLORIDE MONOHYDRATE

First approved in 1960

Details

Stereochemistry	ACHIRAL
Molecular Formula	C16H19N3S.ClH.H2O
Molecular Weight	339.883
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of PROTHIPENDYL HYDROCHLORIDE MONOHYDRATE

Structure Search

SMILES

O.Cl.CN(C)CCCN1C2=CC=CC=C2SC3=CC=CN=C13

InChI

InChIKey=YATJECIBCQMRMY-UHFFFAOYSA-N

InChI=1S/C16H19N3S.ClH.H2O/c1-18(2)11-6-12-19-13-7-3-4-8-14(13)20-15-9-5-10-17-16(15)19;;/h3-5,7-10H,6,11-12H2,1-2H3;1H;1H2

HIDE SMILES / InChI

Molecular Formula	ClH
Molecular Weight	36.461
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	H2O
Molecular Weight	18.0153
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	C16H19N3S
Molecular Weight	285.407
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://www.ncbi.nlm.nih.gov/mesh/67069248 | https://pubchem.ncbi.nlm.nih.gov/compound/14670

PROTHIPENDYL is a neuroleptic azaphenothiazine used to treat anxiety and agitation in psychotic syndromes. It also shows strong antihistamine and anti-emetic actions.

CNS Activity

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Dopamine D1 receptor 106 Target ID: CHEMBL265 Sources: https://www.ncbi.nlm.nih.gov/pubmed/7894260	Antagonist 2849
Dopamine D2 receptor 311 Target ID: CHEMBL339 Sources: https://www.ncbi.nlm.nih.gov/pubmed/7894260\|https://books.google.ru/books?id=nXxZDwAAQBAJ&pg=PT456&lpg=PT456&dq=PROTHIPENDYL retrieved from The SAGE Encyclopedia of Pharmacology and Society edited by Sarah E. Boslaugh	Antagonist 2849

Conditions

Condition	Modality	Targets	Highest Phase	Product
Tranquilizer 4 Sources: http://www.cdsco.nic.in/writereaddata/1961-1970.pdf	Primary		Approved 8583	Unknown Approved Use Unknown

C_max

Value	Dose	Co-administered	Analyte	Population
18 ng/mL EXPERIMENT https://onlinelibrary.wiley.com/doi/abs/10.1002/dta.2319	40 mg single, oral dose: 40 mg route of administration: Oral experiment type: SINGLE co-administered:		PROTHIPENDYL serum	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN
42.6 ng/mL EXPERIMENT https://onlinelibrary.wiley.com/doi/abs/10.1002/dta.2319	80 mg single, oral dose: 80 mg route of administration: Oral experiment type: SINGLE co-administered:		PROTHIPENDYL serum	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN

T_1/2

Value	Dose	Co-administered	Analyte	Population
2.5 h OTHER https://link.springer.com/chapter/10.1007%2F978-3-642-25761-2_10	unknown, oral		PROTHIPENDYL unknown	Homo sapiens population: UNKNOWN age: UNKNOWN sex: UNKNOWN food status: UNKNOWN

Doses

Dose	Population	Adverse events
1280 mg 1 times / day multiple, oral Studied dose Dose: 1280 mg, 1 times / day Route: oral Route: multiple Dose: 1280 mg, 1 times / day Sources: https://pubmed.ncbi.nlm.nih.gov/5325240	unhealthy, 20 years (range: 16-31 years) Health Status: unhealthy Age Group: 20 years (range: 16-31 years) Sex: M Sources: https://pubmed.ncbi.nlm.nih.gov/5325240	Sources: https://pubmed.ncbi.nlm.nih.gov/5325240
960 mg 1 times / day multiple, oral Studied dose Dose: 960 mg, 1 times / day Route: oral Route: multiple Dose: 960 mg, 1 times / day Sources: https://pubmed.ncbi.nlm.nih.gov/5325240	unhealthy, 26 years (range: 14-42 years) Health Status: unhealthy Age Group: 26 years (range: 14-42 years) Sex: F Sources: https://pubmed.ncbi.nlm.nih.gov/5325240	Sources: https://pubmed.ncbi.nlm.nih.gov/5325240
4 g single, oral Overdose Dose: 4 g Route: oral Route: single Dose: 4 g Sources: https://pubmed.ncbi.nlm.nih.gov/7915105	unknown Health Status: unknown Sources: https://pubmed.ncbi.nlm.nih.gov/7915105	Other AEs: Adverse event... Other AEs: Adverse event (grade 5) Sources: https://pubmed.ncbi.nlm.nih.gov/7915105

AEs

AE	Significance	Dose	Population
Adverse event	grade 5	4 g single, oral Overdose Dose: 4 g Route: oral Route: single Dose: 4 g Sources: https://pubmed.ncbi.nlm.nih.gov/7915105	unknown Health Status: unknown Sources: https://pubmed.ncbi.nlm.nih.gov/7915105

Overview

CYP3A4	CYP2C9	CYP2D6	hERG
substrate 1946	substrate 1193	substrate 1388

OverviewOther

Other Inhibitor	Other Substrate	Other Inducer
	CYP1A2 1197 CYP2C19 1119

Drug as victim

Target	Modality	Activity
CYP2C9 1193	substrate 4014 Sources: https://pubmed.ncbi.nlm.nih.gov/28756170/	likely
CYP1A2 1197	substrate 4014 Sources: https://pubmed.ncbi.nlm.nih.gov/28756170/	major
CYP2C19 1119	substrate 4014 Sources: https://pubmed.ncbi.nlm.nih.gov/28756170/	major
CYP2D6 1388	substrate 4014 Sources: https://pubmed.ncbi.nlm.nih.gov/28756170/	minor
CYP3A4 1946	substrate 4014 Sources: https://pubmed.ncbi.nlm.nih.gov/28756170/	minor

Sourcing

Vendor/Aggregator	ID	URL
001 Chemical	DY547352	https://www.001chemical.com/chem/303-69-5
ABI Chem	AC1L24BL
BOC Sciences	303-69-5
Chemieliva Pharmaceutical Co., Ltd	PBCM1267030
Compound Cloud	14669
Compound Cloud	14670
eMolecules	110024654
eMolecules	300468680
eMolecules	31593248
HongKong Chemhere	SCE25807
Molcore	MC547352	https://www.molcore.com/product/303-69-5
MuseChem	R047529
NovoSeek	14670
Smolecule	S540442	http://www.smolecule.com/products/s540442
THE BioTek	bt-280854	https://www.thebiotek.com/product/inhibitors/bt-280854
Toronto Research Chemicals	C427943
Toronto Research Chemicals	P838850
ZINC	ZINC000000001996	http://zinc15.docking.org/substances/ZINC000000001996

PubMed

Title	Date	PubMed
The impact of perfectionism and anxiety traits on action monitoring in major depressive disorder.	2010-07	20473695
Research on antipsychotics in India.	2010-01	21836703
Increased D-amino acid oxidase expression in the bilateral hippocampal CA4 of schizophrenic patients: a post-mortem study.	2009-12	19823762
A double-blind, randomized, parallel group study to compare the efficacy, safety and tolerability of slow-release oral morphine versus methadone in opioid-dependent in-patients willing to undergo detoxification.	2009-09	19686525
Psychotropic medication use among nursing home residents in Austria: a cross-sectional study.	2009-05-21	19460135
Simultaneous prescribing of atypical antipsychotics, conventional antipsychotics and anticholinergics-a European study.	2007-06	17333501
Fatal accident caused by isoflurane abuse.	2002-12	12596784
Application of ammonium peroxidisulfate and metavanadate for spectrophotometric determination of prothipendyl hydrochloride.	2001-08-15	11501795
Different fatal toxicity of neuroleptics identified by autopsy.	2001-04	11313157

Substance Class	Chemical Created by `admin` on `Mon Mar 31 21:37:25 GMT 2025` Edited by `admin` on `Mon Mar 31 21:37:25 GMT 2025`
Record UNII	9G1ILH80SA
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

PROTHIPENDYL HYDROCHLORIDE [MART.]

Preferred Name

English

PROTHIPENDYL HYDROCHLORIDE MONOHYDRATE

Common Name

English

10H-PYRIDO(3,2-B)(1,4)BENZOTHIAZINE-10-PROPANAMINE, N,N-DIMETHYL-, HYDROCHLORIDE, HYDRATE (1:1:1)

Systematic Name

English

Code System Code Type Description

SMS_ID

100000174884